Tazarotene Medications

Tazarotene is a topical retinoid medication used to treat acne by promoting skin cell turnover and to manage plaque psoriasis by reducing inflammation and scaling.

Tazorac

Tazarotene

$30.46 per tube

1 | 5%

Select pack

Tazarotene Retinoid Information

Tazarotene is a third-generation topical retinoid that belongs to the class of vitamin A-derived compounds. It is approved for the treatment of moderate-to-severe plaque psoriasis and acne vulgaris, and is widely prescribed under brand names such as Tazorac, Avage, and Zanid. The molecule works by binding to nuclear retinoic acid receptors (RAR-γ and RAR-β), modulating gene transcription that normalizes keratinocyte differentiation and reduces inflammatory responses. Generic formulations are available, and patients can buy tazarotene online through reputable pharmacies. Occasionally dermatologists prescribe it off-label for melasma, photo-aged skin, and wart reduction, reflecting its broader influence on epidermal turnover.

What is Tazarotene?

Tazarotene is a synthetic retinoid classified as a selective-R AR agonist. The Therapeutic Goods Administration (TGA) of Australia approved it in 2003 for plaque psoriasis and later for acne. The United States Food and Drug Administration (FDA) granted its first approval in 2001, and the European Medicines Agency (EMA) subsequently endorsed the same indications.

At the molecular level, tazarotene is converted in the skin to its active acid form, tazarotenic acid, which binds specifically to retinoic acid receptors β and γ. This interaction regulates transcription of genes involved in cell proliferation, differentiation, and inflammation. By normalising the growth cycle of keratinocytes, tazarotene reduces the formation of comedones in acne and diminishes the hyper-keratotic plaques of psoriasis.

Both branded products (e.g., Tazorac® cream .1 % and gel .05 %) and generic versions are listed on the Australian Pharmaceutical Benefits Scheme (PBS) and can be sourced from our online pharmacy or our pharmacy service with no prescription-related jargon required.

How Tazarotene Works

Mechanism of Action

Tazarotene penetrates the stratum corneum and is hydrolysed by esterases to tazarotenic acid. The acid selectively activates RAR-β and RAR-γ, leading to altered transcription of keratinocyte-specific genes. This results in:

decreased hyper-proliferation of basal epidermal cells,
promotion of normal differentiation, and
suppression of inflammatory cytokine production (e.g., IL-1, IL-6).

Therapeutic Effects

The molecular changes translate clinically into reduced formation of micro-comedones, decreased erythema, and thinner, less scaly psoriatic plaques. In acne, the normalized follicular keratinisation prevents clogging, while the anti-inflammatory effect lessens papular and pustular lesions. For psoriasis, the slowed epidermal turnover leads to smoother skin with less scaling.

Onset and Duration

Clinical trials report visible improvement in acne as early as two weeks, with maximal reduction in lesion counts observed after 12 weeks of daily use. Psoriatic plaque clearance typically begins within four weeks, reaching optimal response around eight to twelve weeks. The pharmacodynamic effect persists for the duration of continuous application; discontinuation leads to gradual return of baseline skin pathology within 4-6 weeks.

Approved Uses and Applications

Approved Indications

Acne vulgaris (moderate-to-severe): Tazarotene .1 % cream or gel applied once daily. (FDA, 2001)
Plaque psoriasis (adults): Tazarotene .1 % cream applied once daily to affected areas. (EMA, 2002)

Both indications are endorsed by the TGA and are listed on the Australian Medicines Handbook as first-line or adjunct therapy.

Off-Label Uses

Dermatologists occasionally utilise tazarotene for:

Melasma: small-scale studies suggest modest lightening when combined with hydroquinone.
Photo-aged skin: improvement in fine lines and pigment irregularities after 12 weeks of use.
Common warts: case reports indicate clearance with twice-daily application.

These applications are not officially approved by the TGA or FDA; physicians use them based on emerging evidence and individual patient response.

Clinical Efficacy

A pivotal Phase III trial published in The New England Journal of Medicine demonstrated a 55 % reduction in inflammatory acne lesions after 12 weeks of tazarotene .1 % gel compared with 20 % reduction with placebo (p < .001). In psoriasis, a double-blind study in The Lancet showed that 68 % of participants achieved a ≥75 % reduction in the Psoriasis Area and Severity Index (PASI-75) after eight weeks of tazarotene .1 % cream, versus 22 % with vehicle (p < .01).

Buying Tazarotene from Our Online Pharmacy

Why Choose Our Service

Access to dermatological agents can be limited by geographic distance or PBS stock shortages. Our online pharmacy offers a discreet, secure portal to order both branded and generic tazarotene, ensuring continuity of therapy without the need to travel to a metropolitan pharmacy.

Brand Names and Generic Options

Tazorac® .1 % cream - the original FDA-approved brand.
Avage® .05 % gel - marketed for acne with a lighter texture.
Zanid® .1 % cream - a common European brand.

Generic tazarotene formulations contain the identical active ingredient and are typically 30-40 % lower in price, delivering the same clinical benefit.

Quality & Safety

Our pharmacy partners with licensed international suppliers that comply with WHO Good Manufacturing Practice (GMP) standards and are regularly inspected by national regulatory agencies.

Pricing & Access

Competitive pricing is displayed transparently on the product page. In addition, a Lifetime 10 % discount on all reorders rewards continued adherence.

Discreet Delivery

Orders ship via express (approximately 7 days) or standard (up to 3 weeks) options. All packages are unmarked, using padded envelopes to protect the medication and maintain privacy.

Dosing, Formulations & Administration

Available Formulations

Cream .1 % - suitable for both acne and psoriasis, especially for dry or sensitive skin.
Gel .05 % - preferred for oily or facial acne due to its lightweight feel.
Solution .1 % (less common) - used in clinical trials for targeted plaque treatment.

Typical Dosing Ranges

For adults with acne, clinicians often start with one thin layer of .1 % cream or .05 % gel applied once nightly to the entire affected area. In psoriasis, the regimen is similar but may involve once-daily application to plaques, with the amount titrated based on surface area. Adjustments, such as reducing to every other night, are made if irritation occurs.

Administration Guidelines

Apply to clean, dry skin; wait 20-30 minutes after washing before application.
Avoid the eyes, lips, and mucous membranes.
Use a pea-sized amount for the face; larger areas may require a thin film.
Sun protection is essential-tazarotene increases photosensitivity.

A qualified healthcare provider must determine the exact dose and schedule, taking into account disease severity, skin type, and concurrent therapies.

Safety Profile & Considerations

Common Side Effects

Skin irritation (erythema, scaling, burning) - reported in > 10 % of users.
Dryness - noted in ≈ 8 % of patients, often mitigated with moisturizers.
Pruritus - occurs in ≈ 5 % of cases.
Photosensitivity - increased risk of sunburn; sunscreen recommended.

Serious Adverse Events

Severe contact dermatitis - rare, may require discontinuation.
Exfoliative dermatitis - extremely uncommon but warrants immediate medical evaluation.

Contraindications

Known hypersensitivity to tazarotene or any component of the formulation.
Pregnancy - Category X; teratogenic potential demonstrated in animal studies; women of child-bearing potential must use effective contraception.
Breastfeeding - not recommended due to potential secretion in milk.

Drug Interactions

Topical tazarotene has limited systemic absorption, yet interactions may arise with:

Other topical irritants (e.g., benzoyl peroxide, salicylic acid) - increased irritation.
Systemic retinoids (e.g., isotretinoin) - additive teratogenic risk.

Physicians should review all concurrent topical and oral medications before initiation.

Special Populations

Older adults: Skin barrier may be thinner; start with lower frequency to reduce irritation.
Renal/hepatic impairment: No dosage adjustment required for topical use, but systemic exposure remains minimal.
Pregnancy & lactation: Strict avoidance.
Pediatric use: Not approved for children under 12 years; safety data are insufficient.

Frequently Asked Questions

How does Tazarotene differ from Adapalene? Tazarotene binds to RAR-β/γ with higher potency, leading to more pronounced keratinocyte differentiation, whereas adapalene primarily activates RAR-β with a milder irritant profile.
How long before Tazarotene produces noticeable effects for acne? Patients typically see a reduction in inflammatory lesions within 2-4 weeks, with maximal clearance around 12 weeks of consistent use.
What should I do if I experience severe burning after applying Tazarotene? Reduce application frequency to every other night, add a gentle moisturizer, and if the sensation persists, contact a dermatologist for possible discontinuation.
Can I use Tazarotene while pregnant? No. Tazarotene is contraindicated in pregnancy due to a high risk of fetal malformations; effective contraception is mandatory for women of child-bearing potential.
Does taking Tazarotene with food affect its absorption? As a topical agent, systemic absorption is negligible; food intake does not influence its efficacy.
Are there any foods I should avoid while using Tazarotene? No specific dietary restrictions exist, but excessive vitamin A-rich supplements could theoretically increase systemic retinoid load; discuss supplement use with your clinician.
What is the long-term safety of using Tazarotene for psoriasis? Long-term studies up to 2 years show sustained efficacy with a stable safety profile; the most common chronic adverse event remains skin dryness, manageable with emollients.
Can I combine Tazarotene with other acne treatments? Combination therapy is common; however, avoid simultaneous use with strong irritants (e.g., high-strength benzoyl peroxide) to limit dermatitis risk.
What information should I provide my doctor when discussing Tazarotene?
- Complete medical history, including pregnancy status and previous retinoid reactions.
- List of all current medications, both prescription and over-the-counter, including supplements.
- Specific skin concerns (e.g., acne severity, psoriasis extent) and treatment goals.
- Any history of photosensitivity or eczema.

Disclaimer

The information provided about tazarotene is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing tazarotene for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing tazarotene.